AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

SkinHealth Systems Inc.

$0.7 -$0.70 (-50.25%)
NASDAQ · 15 Sep 2026 14:25 UTC
Previous Close
$0.7
Day Range
$0.68$0.7
Year Range
$0.55$2.69
Market Cap
90.27M
AVG Volume
2.05M
Trailing/Forward PE
-3.08/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD)
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q272.11M
26 Q164.9M
25 Q482.37M
25 Q370.66M
25 Q278.19M
25 Q169.58M
24 Q483.5M
24 Q378.8M
24 Q290.59M
24 Q181.4M
Net Income (USD)
-20M-10M010M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-2.67M
26 Q1-6.6M
25 Q4-8.1M
25 Q3-11.03M
25 Q219.71M
25 Q1-10.1M
24 Q4-10.33M
24 Q3-18.29M
24 Q2202K
24 Q1-679K
Operating Income (USD)
-30M-20M-10M010M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q23.57M
26 Q1-1.8M
25 Q4162K
25 Q3-6.24M
25 Q2-2.7M
25 Q1-12.02M
24 Q4-7.16M
24 Q3-21.52M
24 Q2-22.11M
24 Q1-16.99M
EBITDA (USD)
-10M010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q212.99M
26 Q14.88M
25 Q46.92M
25 Q34.1M
25 Q228.26M
25 Q1-542K
24 Q4-2.7M
24 Q3-4.32M
24 Q211.22M
24 Q110.34M
Cash Flows (USD)
-20M-10M010M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q21.47M
26 Q1-7.2M
25 Q413.81M
25 Q38.56M
25 Q210.79M
25 Q11.85M
24 Q415.61M
24 Q38.22M
24 Q24.16M
24 Q1-18.66M
EPS (USD)
-0.15-0.1-0.05-00.0524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.02
26 Q1-0.05
25 Q4-0.06
25 Q3-0.09
25 Q20.03
25 Q1-0.08
24 Q4-0.08
24 Q3-0.15
24 Q2-0.1
24 Q1-0.1
Expenses (USD)
-20M020M40M60M80MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q246.97M
26 Q147.85M
25 Q454.26M
25 Q352.96M
25 Q250.67M
25 Q161.75M
24 Q460.37M
24 Q364.26M
24 Q265.09M
24 Q167.15M
Cash & Debt (USD)
0200M400M600M800MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2206.1M
26 Q1204.4M
25 Q4232.67M
25 Q3219.4M
25 Q2212M
25 Q1373.03M
24 Q4370.06M
24 Q3358.89M
24 Q2349.54M
24 Q1444.63M
Debt ratios
-20020406024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Debt ratios by quarter
PeriodDebt ratios
26 Q25.57
26 Q13.69
25 Q43.77
25 Q35.48
25 Q27.96
25 Q153.17
24 Q413.62
24 Q39.62
24 Q2-6.64
24 Q1-8.25
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Margins by quarter
PeriodMargins
26 Q268.42%
26 Q168.41%
25 Q464.39%
25 Q364.59%
25 Q262.81%
25 Q169.82%
24 Q462.69%
24 Q351.58%
24 Q245.19%
24 Q159.41%
Return on Capital
-40%-20%0%20%40%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Return on Capital by quarter
PeriodReturn on Capital
26 Q2-4.8%
26 Q1-11.96%
25 Q4-13.27%
25 Q3-16.8%
25 Q226.64%
25 Q1-21.92%
24 Q4-19.94%
24 Q3-30.63%
24 Q20.29%
24 Q1-1.07%
Shares Outstanding
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2129.6M
26 Q1127.79M
25 Q4127.44M
25 Q3126.89M
25 Q2126.07M
25 Q1125.08M
24 Q4124.4M
24 Q3124.06M
24 Q2123.72M
24 Q1123.12M
Book Value Per Share (USD)
00.20.40.624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20.43
26 Q10.43
25 Q40.48
25 Q30.52
25 Q20.59
25 Q10.37
24 Q40.42
24 Q30.48
24 Q20.56
24 Q10.51
Total Assets (USD)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SKIN Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2486.6M
26 Q1473.2M
25 Q4499.8M
25 Q3503.64M
25 Q2507.56M
25 Q1673.82M
24 Q4685.68M
24 Q3699.55M
24 Q2711.83M
24 Q1844.74M
Employee Count
05001K1.5K202020212022202320242025
SKIN Employee Count by quarter
PeriodEmployee Count
2025613
2024769
2023881
20221.03K
2021704
2020406
PE Ratio
406080100med 66.05Jan 23Feb 23Mar 23Apr 23May 23Jun 23Aug 23
SKIN PE Ratio by quarter
PeriodPE Ratio
Aug 2348.43
Jul 2350.6
Jul 2349.73
Jul 2351.97
Jul 2351.1
Jun 2351.97
Jun 2348.24
Jun 2355.07
Jun 2354.08
Jun 2351.53
May 2352.15
May 2363.58
May 2364.82
May 2359.72
Apr 2365.24
Apr 2373.84
Apr 2376.68
Apr 2370.25
Mar 2371.9
Mar 2368.94
Mar 2364.39
Mar 2363.53
Mar 2373.15
Feb 2383.35
Feb 2383.87
Feb 2389.79
Feb 2395.41
Jan 2384.83
Jan 2383.06
Jan 2379.43
Jan 2369.6
Dec 2267.3
Dec 2266.86
Dec 2270.85
Free Cash Flow Yield
-20%0%20%40%med 17.78%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SKIN Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2618.34%
Sep 2618.34%
Sep 2618.74%
Aug 2618.74%
Aug 2619.65%
Aug 2619.25%
Aug 2619.42%
Jul 2629.64%
Jul 2627.75%
Jul 2624.08%
Jul 2622.34%
Jul 2627.99%
Jun 2630.78%
Jun 2630.65%
Jun 2631.08%
Jun 2633.44%
May 2626.26%
May 2629.54%
May 2631.56%
May 2635.03%
May 2631.83%
Apr 2632.3%
Apr 2630.11%
Apr 2630.61%
Apr 2630.36%
Mar 2634.13%
Mar 2624.32%
Mar 2621.64%
Mar 2625.45%
Feb 2627.9%
Feb 2630.87%
Feb 2627.9%
Feb 2622.67%
Jan 2619.34%
Jan 2618.96%
Jan 2619.34%
Jan 2619.87%
Jan 2620.72%
Dec 2519.87%
Dec 2518.96%
Dec 2520.72%
Dec 2519.87%
Nov 2519.6%
Nov 2521.98%
Nov 2522.67%
Nov 2520.72%
Oct 2520.23%
Oct 2520.81%
Oct 2520.23%
Oct 2520.09%
Oct 2517.22%
Sep 2514.69%
Sep 2512.69%
Sep 2511.44%
Sep 2514.11%
Aug 2513.91%
Aug 2513.09%
Aug 2513.27%
Aug 2515.31%
Aug 2515.6%
Jul 2513.33%
Jul 2515.01%
Jul 2512.49%
Jul 2510.47%
Jun 2512.24%
Jun 2514.82%
Jun 2515.6%
Jun 2514.91%
May 2514.64%
May 2514.82%
May 2513.71%
May 2512.76%
May 256.59%
Apr 257.58%
Apr 258.88%
Apr 257.15%
Apr 256.26%
Mar 255.69%
Mar 255.73%
Mar 255.69%
Mar 25-8.44%
Feb 25-7.46%
Feb 25-6.81%
Feb 25-6.57%
Feb 25-7.08%
Jan 25-6.57%
Jan 25-6.34%
Jan 25-6.3%
Jan 25-7.08%
Jan 25-6.65%
Dec 24-6.77%
Dec 24-7.51%
Dec 24-6.94%
Dec 24-7.31%
Nov 24-7.41%
Nov 24-7.72%
Nov 24-7.17%
Nov 24-3.35%
Nov 24-3.29%
Oct 24-3.31%
Price to Sales
0.20.40.60.811.2med 0.55Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SKIN Price to Sales by quarter
PeriodPrice to Sales
Sep 260.31
Sep 260.31
Sep 260.31
Aug 260.31
Aug 260.29
Aug 260.3
Aug 260.3
Jul 260.3
Jul 260.32
Jul 260.36
Jul 260.39
Jul 260.31
Jun 260.28
Jun 260.29
Jun 260.28
Jun 260.26
May 260.33
May 260.3
May 260.28
May 260.25
May 260.37
Apr 260.36
Apr 260.39
Apr 260.38
Apr 260.38
Mar 260.34
Mar 260.48
Mar 260.54
Mar 260.48
Feb 260.44
Feb 260.4
Feb 260.44
Feb 260.54
Jan 260.63
Jan 260.64
Jan 260.63
Jan 260.61
Jan 260.59
Dec 250.61
Dec 250.64
Dec 250.59
Dec 250.61
Nov 250.62
Nov 250.55
Nov 250.54
Nov 250.59
Oct 250.58
Oct 250.57
Oct 250.58
Oct 250.59
Oct 250.68
Sep 250.8
Sep 250.93
Sep 251.03
Sep 250.83
Aug 250.85
Aug 250.9
Aug 250.89
Aug 250.77
Aug 250.59
Jul 250.69
Jul 250.62
Jul 250.74
Jul 250.88
Jun 250.76
Jun 250.62
Jun 250.59
Jun 250.62
May 250.63
May 250.62
May 250.67
May 250.73
May 250.42
Apr 250.37
Apr 250.31
Apr 250.39
Apr 250.45
Mar 250.49
Mar 250.49
Mar 250.49
Mar 250.46
Feb 250.52
Feb 250.57
Feb 250.6
Feb 250.55
Jan 250.6
Jan 250.62
Jan 250.62
Jan 250.55
Jan 250.59
Dec 240.58
Dec 240.52
Dec 240.56
Dec 240.54
Nov 240.53
Nov 240.51
Nov 240.55
Nov 240.55
Nov 240.56
Oct 240.56
EV/EBITDA
050100150med 16.88Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SKIN EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 268.71
Sep 268.71
Sep 268.65
Aug 268.65
Aug 268.5
Aug 268.56
Aug 268.54
Jul 265.67
Jul 265.81
Jul 266.13
Jul 266.32
Jul 265.79
Jun 265.6
Jun 265.6
Jun 265.58
Jun 265.44
May 265.93
May 265.68
May 265.55
May 265.36
May 266.61
Apr 266.57
Apr 266.77
Apr 266.72
Apr 266.75
Mar 266.42
Mar 267.49
Mar 267.95
Mar 2610.45
Feb 2610.01
Feb 269.57
Feb 2610.01
Feb 2611.06
Jan 2612.01
Jan 2612.15
Jan 2612.01
Jan 2611.84
Jan 2611.58
Dec 2511.84
Dec 2512.15
Dec 2511.58
Dec 2511.84
Nov 2511.93
Nov 2511.23
Nov 2511.06
Nov 2511.58
Oct 2516.66
Oct 2516.42
Oct 2516.66
Oct 2516.72
Oct 2518.18
Sep 2519.95
Sep 2521.84
Sep 2523.36
Sep 2520.44
Aug 2520.62
Aug 2521.41
Aug 2521.23
Aug 2519.46
Aug 25105.44
Jul 25114.33
Jul 25107.49
Jul 25118.43
Jul 25131.07
Jun 25119.79
Jun 25108.18
Jun 25105.44
Jun 25107.83
May 25108.86
May 25108.18
May 25112.62
May 25117.06
May 2523.37
Apr 2522.09
Apr 2520.86
Apr 2522.6
Apr 2523.89
Mar 2524.91
Mar 2524.83
Mar 2524.91
Mar 2517.03
Feb 2518
Feb 2518.8
Feb 2519.14
Feb 2518.45
Jan 2519.14
Jan 2519.48
Jan 2519.54
Jan 2518.45
Jan 2519.02
Dec 2418.85
Dec 2417.94
Dec 2418.63
Dec 2418.17
Nov 2418.06
Nov 2417.71
Nov 2418.34
Nov 2324.09
Nov 2327.76
Oct 2328.52
Price/Operating Cashflow
050100150med 5.16Aug 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SKIN Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 264.13
Sep 264.13
Sep 264.04
Aug 264.04
Aug 263.86
Aug 263.94
Aug 263.9
Jul 263.03
Jul 263.23
Jul 263.73
Jul 264.02
Jul 263.21
Jun 262.91
Jun 262.93
Jun 262.89
Jun 262.68
May 263.42
May 263.04
May 262.84
May 262.56
May 262.94
Apr 262.89
Apr 263.1
Apr 263.05
Apr 263.08
Mar 262.74
Mar 263.84
Mar 264.32
Mar 263.73
Feb 263.4
Feb 263.08
Feb 263.4
Feb 264.19
Jan 264.91
Jan 265.01
Jan 264.91
Jan 264.78
Jan 264.58
Dec 254.78
Dec 255.01
Dec 254.58
Dec 254.78
Nov 254.85
Nov 254.32
Nov 254.19
Nov 254.58
Oct 254.57
Oct 254.44
Oct 254.57
Oct 254.6
Oct 255.37
Sep 256.3
Sep 257.29
Sep 258.09
Sep 256.55
Aug 256.65
Aug 257.07
Aug 256.97
Aug 256.04
Aug 255.32
Jul 256.22
Jul 255.53
Jul 256.64
Jul 257.93
Jun 256.78
Jun 255.6
Jun 255.32
Jun 255.56
May 255.67
May 255.6
May 256.05
May 256.5
May 258.79
Apr 257.64
Apr 256.52
Apr 258.1
Apr 259.25
Mar 2510.18
Mar 2510.1
Mar 2510.18
Nov 2494.19
Nov 2495.92
Oct 2495.35
Oct 2492.46
Oct 2490.15
Oct 2485.52
Sep 2479.74
Sep 2483.21
Sep 2486.68
Sep 2481.48
Aug 24103.44
Aug 2499.97
Aug 2481.48
Aug 2464.72
Aug 2410.73
Jul 2412.31
Jul 2412.31
Jul 2413.82
Jul 2413.82
Jun 2413.2
Price to Book
02468med 2.84Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SKIN Price to Book by quarter
PeriodPrice to Book
Sep 261.63
Sep 261.63
Sep 261.6
Aug 261.6
Aug 261.52
Aug 261.55
Aug 261.54
Jul 261.59
Jul 261.7
Jul 261.95
Jul 262.11
Jul 261.68
Jun 261.53
Jun 261.53
Jun 261.51
Jun 261.41
May 261.79
May 261.59
May 261.49
May 261.34
May 261.8
Apr 261.78
Apr 261.91
Apr 261.87
Apr 261.89
Mar 261.68
Mar 262.36
Mar 262.65
Mar 262.2
Feb 262.01
Feb 261.82
Feb 262.01
Feb 262.47
Jan 262.9
Jan 262.96
Jan 262.9
Jan 262.82
Jan 262.71
Dec 252.82
Dec 252.96
Dec 252.71
Dec 252.82
Nov 252.86
Nov 252.55
Nov 252.47
Nov 252.71
Oct 252.44
Oct 252.37
Oct 252.44
Oct 252.45
Oct 252.86
Sep 253.36
Sep 253.88
Sep 254.31
Sep 253.49
Aug 253.54
Aug 253.77
Aug 253.71
Aug 253.22
Aug 254.15
Jul 254.86
Jul 254.32
Jul 255.19
Jul 256.19
Jun 255.3
Jun 254.37
Jun 254.15
Jun 254.34
May 254.43
May 254.37
May 254.73
May 255.08
May 252.74
Apr 252.38
Apr 252.03
Apr 252.52
Apr 252.88
Mar 253.17
Mar 253.15
Mar 253.17
Mar 252.7
Feb 253.05
Feb 253.34
Feb 253.47
Feb 253.22
Jan 253.47
Jan 253.59
Jan 253.61
Jan 253.22
Jan 253.43
Dec 243.37
Dec 243.03
Dec 243.28
Dec 243.12
Nov 243.07
Nov 242.95
Nov 243.18
Nov 242.91
Nov 242.97
Oct 242.95
SkinHealth Systems Inc.
SKIN
Stockpicker

Video analysis: SKIN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SKIN

SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit

globenewswire.com · 15 Sep 2026

SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit

HydraScalp with Keravive study highlights improvements in scalp hydration and overall scalp quality following a single treatment Hydrafacial study shows improvements in skin hydration and overall skin quality following a series of Hydrafacial treatments across all Fitzpatrick skin types I-VI LONG BEACH, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (NASDAQ: SKIN), home to flagship brand Hydrafacial™, today announced that findings from two new clinical studies evaluating HydraScalp™ with Keravive™ and Hydrafacial™ treatments will be presented at the Science of Skin Summit, September 17-20, 2026, in Austin, Texas.

Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers

globenewswire.com · 8 Sep 2026

Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers

LONG BEACH, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN), home to Hydrafacial, today announced the launch of two new Hydrafacial Treatment Enhancers: HydraGlow Pre-Extraction Peel and Hydralock HA Biocellulose Mask.

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

globenewswire.com · 26 Aug 2026

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

National nine-city education series expands Hydrafacial's industry-leading provider training platform National nine-city education series expands Hydrafacial's industry-leading provider training platform

SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored

zacks.com · 11 Aug 2026

SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored

Examine the evolution of SkinHealth Systems Inc.'s (SKIN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Herbalife (NYSE:HLF) versus Beauty Health (NASDAQ:SKIN) Head to Head Comparison

defenseworld.net · 11 Aug 2026

Herbalife (NYSE:HLF) versus Beauty Health (NASDAQ:SKIN) Head to Head Comparison

Herbalife (NYSE: HLF - Get Free Report) and Beauty Health (NASDAQ: SKIN - Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation. Volatility and Risk Herbalife has a beta

SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript

seekingalpha.com · 7 Aug 2026

SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript

SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript

Beauty Health Q2 Earnings Call Highlights

marketbeat.com · 7 Aug 2026

Beauty Health Q2 Earnings Call Highlights

Beauty Health NASDAQ: SKIN reported second-quarter revenue at the low end of its guidance range as cautious capital spending by providers continued to weigh on equipment sales, while stronger gross margins and expense discipline lifted adjusted EBITDA above expectations.

SkinHealth Systems Inc. (SKIN) Reports Q2 Earnings: What Key Metrics Have to Say

zacks.com · 6 Aug 2026

SkinHealth Systems Inc. (SKIN) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for SkinHealth Systems Inc. (SKIN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.